For condition-specific protocols, including ACL, Achilles, and rotator cuff dosing, see our upcoming article, BPC-157 Stacking and Injury Protocol Guide
The 67.4% in-vitro MAO-A inhibition behind the serotonergic, stimulant and tyramine entries is a serotonin-syndrome risk nobody has quantified in a human
Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or [PMID: 10672991] Laboratory literature summary: Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis
DOI: 10.7759/cureus.94838 #ClinicalResearch #RealWorldEvidence #LatePhaseStudies #PostMarketingStudy #MulticenterStudy #Osteoarthritis #Polmacoxib #PatientCare #HealthcareInnovation #PMOS To view or add a comment, sign in Percutaneous Cryoneurolysis for Above-Knee Phantom Limb Pain: Pilot Study Findings A new pilot study in RAPM investigated whether treating four major nerves in the thigh with ultrasound-guided percutaneous cryoneurolysis could reduce phantom limb pain in patients with above-knee amputations (AKA)
Stacks : Semaglutide (weight loss), Tesamorelin (composition), NAD+ IV (energy)